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Abstract 
Targeting of G-protein coupled receptors (GPCRs) like somatostatin (SST) could 
have a potential interest in delivery of anti-cancer agents to tumor cells. Attachment 
of SST to different nano-carriers e.g., polymeric nanoparticles is limited due to the 
difficulty of interaction between SST itself and those nano-carriers. Furthermore, 
the instability problems associated with the final formulation.  Attaching of SST to 
gold nanoparticles (AuNPs) using the positive and negative charge of SST and 
citrate-AuNPs could be considered a new technique to get stable non-aggregated 
AuNPs coated with SST. Different analyses techniques have been performed to 
proof the principle of coating between AuNPs and SST. Furthermore, cellular 
uptake study on HCC-1809 cell lines has been investigated to show the ability of 
AuNPs coated SST to enter the cells via SST receptors. Dynamic light scattering 
(DLS) indicated a successful coating of SST on the MUA-AuNPs surface. 
Furthermore, all the performed analysis including DLS, SDS-PAGE and UV-VIS 
absorption spectra indicated a successful coating of AuNPs with SST. Cellular 
uptake study on HCC-1806 cell lines showed that the number of AuNPs-SST per 
cell is signiﬁcantly higher compared to citrate-AuNPs when quantified using 
inductively coupled plasma spectroscopy. Moreover, the binding of AuNPs-SST to 
cells can be suppressed by addition of antagonist, indicating that the binding of 
AuNPs-SST to cells is due to receptor-specific binding. In conclusion, AuNPs 
could be attached to SST via adsorption to get stable AuNPs coated SST. This new 
formulation has a potential to target SST receptors localized in many normal and 
tumor cells. 
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Introduction 
Gold nanoparticles (AuNPs) are considered to be very important and applicable tool 
in nanotechnology. This is due to their easy surface functionalization and/ or  bio-
conjugation, stability and biocompatibility. They have been the subjects of many 
studies and many applications in medicine and in biology, such as immunoassays, 
drug targeting of cancer cells and in biomedical research (1-2). AuNPs were 
delivered to ovarian cancer cells that express the epidermal growth factor receptor 
and the folate receptor, the ovarian cell took all particles by active transport (3). It 
was found that tumor cells can be killed by excitation of internalized AuNPs, the 
internalized AuNPs were excited by laser beam which killed the cancer cells (4).   
SSTRs are members of the G-protein coupled receptors (GPCRs) super family (5-
6). There are five different subtypes of SSTRs (SSTR1-5), SSTR2 having been 
classified into two subtypes, SSTR2A and SSTR2B (7-8). The blocking of SSTRs 
with antagonist suppresses the interaction of the peptide agonist with SSTRs (9). 
SSTRs are present in the surface of numerous normal and diseased cells; they are 
expressed in normal tissues such as the pituitary gland and pancreas (8, 10). SSTRs 
are also expressed in many tumor cells i.e. small cell and non-small lung cancer 
lung cancer (11-13), neuroendocrine tumors and breast cancer (14).  
Receptor-mediated endocytosis is an important example of a specific internalization 
mechanism following ligand binding to their receptor (15-17). It allows for an 
import of extracellular molecules for around 1000-fold increase of the intracellular 
concentration of macromolecules (18-20). In the process of endocytosis, the plasma 
membrane is engulfed inwards from specialized membrane micro-domains forming 
either clathrin or caveolin-coated pits (20). 
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SST has many functions in mammals, it can controls the secretion of growth 
hormones (21). Moreover, it is widely distributed throughout the central nervous 
system and peripheral tissues employing numerous roles in the central nervous 
system (22-23). Furthermore, SST inhibits the regulation of many endogenous cell 
functions, including the modulation of neurotransmission, motility, cell 
proliferation and cell secretion (24-25).  Hence, SST could be considered promising 
molecules in drug delivery applications. The limited stability and the presence of 
many functional groups within SST make the interaction with other compounds 
such as PEGylation with thiolated-PEG is difficult. Many trials have been 
performed in our laboratory for PEGylation of SST or even attaching any other 
polymer to coat AuNPs. Such trials showed the difficulty of such attachment due to 
the numerous functional groups of SST. Moreover, it may affect the structure and 
integrity of SST.  
Up to date and according to our research in literature we have the first attempt to 
rationally develop and formulate a novel stable non-aggregated AuNPs coated with 
SST. AuNPs coated with SST system has a potential to active target SST receptors 
for diagnostic as well as therapeutic purposes. The novel prepared system utilizing 
the absorption between the positively charged SST and the negatively charged 
citrate-AuNPs at neutral pH.  AuNPs were prepared by citrate reduction method 
and coated with 11-MUA to facilitate the binding with SST. Furthermore, the 
stability and the ability to adsorb SST to either citrate-coated-AuNPs or 11-MUA-
coated AuNPs were investigated. The prepared citrate-AuNPs, MUA-AuNPs and 
AuNPs coated with different concentrations of SST were examined for their size, 
polydispersity and surface charge. Moreover, the dissociation and adsorption of 
SST to AuNPs were also studied and confirmed using sodium dodecyl sulphate and 
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polyacrylamide gel electrophoresis. Cellular uptake study for citrate-AuNPs, 
AuNPs-SST and AuNPs-SST together with antagonist was also performed using 
HCC-1806 cell lines. In addition, the amounts of Au internalized into the cells were 
quantified using inductively coupled plasma spectroscopy (ICP-OES).
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Materials and methods 
Materials 
Somatostatin acetate (SST) was kindly supplied from CuraMED Pharma GmbH 
(karlsruhe, Germany). Hydrogen tetrachloroaurate tri-hydrate, 11-Mercaptoundecanoic 
acid (11-MUA), RPMI 1640 medium, bovine serum albumen, Chloroauric acid 
(HAuCl4) and cyn-154806 trifluoroacetate (TFA) were purchased from Sigma Aldrich 
(Steinheim, Germany). Tri-sodium citrate dihydrate, sodium chloride, sodium 
hydroxide, nitric acid, hydrochloric acid, triethylamine, sodium dihydrogen phosphate, 
disodium hydrogen phosphate were purchased from Merck (Darmstadt, Germany). 
Dulbecco`s phosphate buff red saline (pH 7.4), Dulbecco's Modified Eagle Medium, 
and Leibovitzs L-15 were purchased from Invitrogen, (Paisley, UK). Triple negative 
breast cancers cells (HCC-1806) were kindly supplied from Dr. Abdellatif Bouazzaoui 
(Haematology and Internal Oncology, Regensburg University, Germany). The purified 
water used for all experiment was obtained using a Milli-Q water purification system 
from Millipore (Schwalbach, Garmany).  Any other chemicals and solvents were of 
analytical grade. 
Preparation of AuNPs capped with SST 
Preparation of citrate-AuNPs 
First, citrate-AuNPs were prepared according to apreviously reported procedure (26-
28). Briefly, 3mL of 38.8mM tri-sodium citrate solution were added to 100mL of 
0.3mM Chloroauric acid (HAuCl4) solution in a 250mL round bottom flask. The 
reaction mixture stirred vigorously and heated under reflux. Refluxing was continued 
for 15 minutes, and then the prepared AuNPs was left to cool at room temperature (28). 
Stirring was continued for an additional 15 minutes. AuNPs were purified from larger 
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aggregates by centrifugation for 30 minutes at 2,450 ×g using (Avanti centrifuge J-E/ 
Beckman coulter GmbH, Germany).  
Stabilization of the synthesized citrate-AuNPs 
11-MUA was deposited on the gold surface to facilitate the electrostatic binding 
between SST and AuNPs (29-31). Briefly, 1mL of 1mM stock solution of 11-MUA 
was added to 20mL of the prepared AuNPs solution in a 100mL Erlenmeyer flask. 
After adjusting the pH to 11, the AuNPs were incubated with 11-MUA under 
continuous stirring at 600rpm at room temperature overnight. This allows sufficient 
exchange of citrate anions with 11-MUA on the particle surface. The stabilized 
particles were purified by centrifugation at 15,700×g for 20 minutes in a falcon tube 
using an Avanti centrifuge J-E/ Beckman coulter GmbH, Germany. The supernatant 
was decanted and the precipitate was resuspended again in Millipore water (30). 
Coating of MUA-AuNPs with SST 
First, different concentrations of SST (20, 40, 60, 100 and 200nM) were studied to 
show the optimal concentration for coating. In brief, 3mL of the prepared MUA-
AuNPs were mixed with 100µL of 10mM NaCl as isotonic solution and stirred for 30 
minutes(32). Then the stabilized MUA-AuNPs were added drop-wise to 10µL of 
different concentrations of SST to determine the optimum concentration of SST that 
can load to AuNPs. The solution was stirred for another 30 minutes. The stabilized 
AuNPs-SST were purified by centrifugation at 15,700×g for 15 minutes, using 
(Eppendorf centrifuge 5415R, Hamburg, Germany), the supernatant was decanted and 
the precipitate was re-suspended again in Millipore water. The steps of deposition and 
purifications are shown in (Figure 1).  
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Insert Figure 1 here 
Characterization of AuNPs capped with SST 
Size and surface charge  
To determine the size, count rate and zeta potential of AuNPs, the samples were 
adjusted to 25±1.0
o
C and laser light scattering analysis was performed with an incident 
laser beam of 633nm at a scattering angle of 90
o
 using the Malvern zetasizer nano 6.01 
(Malvern Instruments GmbH, Herrenberg, Germany). The sampling time was set 
automatically. Moreover, three measurements were allowed to perform each 10 sub-
runs and, all measurements were carried out in aqueous solution. The results were 
calculated from the average of three independent measurements (28). 
Dissociation of SST from AuNPs-SST by solid sodium dodecyl sulfate 
Sodium dodecyl sulfate, (SDS) was used to adsorb and dissociate the AuNPs from the 
formulated AuNPs-SST leaving SST free in solution. Then, the free SST was 
quantified using HPLC. In brief, 3mL of the purified AuNPs-SST were incubated with 
3mg solid SDS at room temperature and left overnight. SDS adsorbed the AuNPs from 
AuNPs-SST leaving SST free in the supernatant which it can be measured and 
identified by HPLC. 
HPLC analysis was performed for SST using a system with a Degasser (Knauer, 
Berlin, Germany), LC-10AT pump, FCV-10ATVP gradient mixer, SIL-10ADVP 
autosampler, CTO-6A column oven, SPD-10AV UV-detector, RF-551 fluorescence 
detector and SCL-10AVP controller (Shimadzu, Duisburg, Germany). HPLC analysis 
was performed for SST using linear gradient method from 26% to 39% acetonitrile in 
water, with 0. 1% TFA, as mobile phase was applied over 15 minutes at a flow rate of 
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1.0mL/minute. The samples were separated at a temperature of 40°C using a C18-
reversed Precolumn (LC 318, 4.6mMx5.0mm). Chromatograms were detected by UV 
detection at 210nm and 274nm (33).  
Identification of the attached SST to AuNPs using sodium dodecyl sulfate 
polyacrylamide gel electrophoresis 
The adsorbed SST to AuNPs was determined using SDS-PAGE as previously reported 
(34-35). In brief, 21µL of AuNPs-SST was mixed with 7µL modified SDS-PAGE 
sample buffer. Without heating, the samples were loaded in duplicates onto a 6% SDS-
PAGE gel. Then, the normal gel running procedure was followed. Putamol was used to 
over fill the separating gel. Electrophoresis was run in a constant mode at 100mA using 
Pharmacia Biotech Electrophoresis Power Supply EPS (Bridge Path Scientific, 4841 
International Boulevard, Frederick, MD 21703). It was running on discontinuous buffer 
system. The running was also using separating gels (6%) and collecting gel (1.2mL 
acrylimide, 2mL collecting gel buffer, 5µL TEMED and 80µL APS 10%). 10µL of 
protein ladder of 19, 26, 34, 48, 85, or 117kDa were used as control protein. Gels were 
stained by Coomassie Brilliant Blue G-25 dispersion. 
UV-VIS spectroscopy of AuNPs and AuNP-SST 
UV-VIS absorption spectra of the citrate-AuNPs, MUA-AuNPs and AuNPs decorated 
with SST were recorded using an Uvikon 941UV-VIS absorbance spectrophotometer 
(Kontron Instruments GmbH). It was taken five spectra of each gold colloid suspension 
in the range from 400to700nm. The absorbance measurements were made using 0.5cm 
path length quartz cuvettes. The SPR is clearly visible as a peak in the range between 
514 and 550nm. 
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Cellular uptake study 
HCC1806 cells were used to study the cellular uptake of SST-decorated AuNPs. HCC-
1806 cells express all types of SSTRs. SSTRs expression was confirmed by Reverse 
Transcription Polymerase Chain Reaction (RT-PCR) (36). HCC-1806 cells were 
cultured in T-75 tissue culture flasks in RPMI 1640 supplemented with 10% FCS (37).  
Cellular uptake study of AuNPs-SST using inductively coupled plasma-optical 
emission spectroscopy ICP-OES 
To determine quantatively the number of AuNPs entered per cell, HCC-1806 cells 
were incubated for 1 hour at 37°C with 1mL of 100nM of citrate-AuNPs and AuNPs-
SST. The incubation was performed in 1mL of serum-containing culture medium with 
serum free Leibowitz medium in T-75 tissue culture flasks. To displace the bound 
AuNPs-SST, the cells were incubated prior to the experiment for 20 minutes with 
100µL of 1mM antagonist (cyn-164806). The AuNPs concentrations were determined 
in 96-well plate using an Uvikon 941UV-VIS absorbance spectrophotometer (Kontron 
Instruments GmbH) (38). To harvest cells, 2mL of trypsin-EDTA was added to the 
flask. The flasks were incubated at 37±0.5°C for 3 minutes to allow cell detachment. 
The cells were washed with DPBS two times, followed by centrifugation at 300×g 
(18±0.5°C) for 5 minutes in order to pellet the cells. The cells were transferred to a 
5mL glass vials.  
ICP-OES sample preparation and determination of AuNPs 
This technique is specifically used to determine the concentration of Au
3+
 metals, 
minor and major concentrations as a previously reported (30, 39). Typically, 500µL of 
each sample containing AuNPs was mixed with 200µL of freshly prepared aqua regia 
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then diluted to 5mL with Millipore water. The Au
3+
 content of the digested cells was 
determined using ICP-OES on a JY-70 PLUS (Jobin Yvon Instruments S.A.). The 
plasma flow was 16mL/minute argon. Concentrations of 1, 10 and 100ppm were used 
as a standard concentration of gold (III) chloride. The numbers of AuNPs per cell were 
determined by ICP-OES (for details of calculation refer the Supporting Information). 
Statistical analysis 
Cellular uptake study was subjected to statistical analysis using One-way analysis of 
variance (ANOVA). Minitab® 16 Statistical Software with the Tukey’s multiple 
comparison was employed for comparing the formulations with each other. Statistically 
significant differences were assumed when p<0.05.  
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Results and discussion 
Preparation and characterization of AuNPs 
 Citrate coated AuNPs were synthesized as reported previously (30). During this 
synthesis, a color change was observed when tri-sodium citrate was added to HAuCl4 
solution. The solution was initially of yellowish color. After the citrate was added, the 
color changed first to light blue, dark blue, then purple, dark purple, and finally red to 
purple in color (Figure 2). 
  Insert Figure 2 here 
The obtained series of colour change indicated the formation of small and uniform 
citrate-AuNPs via the citrate-reduction method using a molar ratio of 3:1 tri-sodium 
citrate to HAuCl4. Furthermore, the formulated citrate-AuNPs were uniform in particle 
size of 19.3±0.5nm and had a negative surface charge of - 43.4±0.5mV (Figure 3). 
Size (hydrodynamic diameter), Polydispersity index (PDI) and zeta potential of 
particles are parameters that indicate the stability of nanoparticles(40-41). High PDI 
indicates the heterogeneity of the particle size in suspension. While smaller PDI values 
indicate the homogeneity of the particle size in suspension. It was reported that PDI 
lower than 0.2 is considered to be ideal hence, the particle size distribution falls within 
a narrow range of size (40, 42-45). The surface charge also plays an important role in 
the stability of the nanoparticles and the magnitude of zeta potential is indicative of the 
colloidal stability of the system (46).  
In addition, the mean count rate and PDI were monitored as shown in (Figure 3). The 
high-count rate 185 kpcs, indicated that the concentration of nanoparticles was high 
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enough for measurements. Furthermore, the PDI was very small 0.16, indicating that 
the colloidal AuNPs were uniform and has a very narrow size distribution range.  
Insert Figure 3 here 
Stabilization of the synthesized AuNPs using 11-MUA 
A stronger stabilizing agent, 11-MUA, was used instead of citrate to achieve successful 
coating of AuNPs with SST. 11-MUA is a thiol compound that binds strongly to gold 
surfaces. Citrate-AuNPs were coated with 11-MUA at pH 11. The carboxyl group of 
11-MUA is deprotonated at pH 11 and can stabilize the particle dispersion via 
electrostatic repulsion (32). After coating of AuNPs with 11-MUA, the size increased 
to 23.5±0.05nm with a PDI of about 0.2 (Figure 4). After the purification of MUA-
AuNPs, the PDI decreased to a value of 0.1 indicating that the free 11-MUA was 
removed from the colloidal solution, and MUA-AuNPs turned to a more stable and 
more monodisperse colloidal solution.  
It was found that the zeta potential was highly negative -73.2±0.06mV for crude MUA-
AuNPs. After purification, the zeta potential increased to become less negative -
65.3±0.1mV, but still high enough to stabilize the particles in an aqueous environment 
as shown in (Figure 5). On the same time, this highly negative charge is ideal for an 
adsorptive immobilization of SST.  
Insert Figures 4 and 5 here 
Influence of different ionic strength on the stability of MUA-AuNPs  
Ionic strength is very important for the stability of colloidal nanoparticles (47). In 
addition, ionic strength is considered one of the most important factors that influence 
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the adhesion of a molecule to nanoparticles surfaces (30). To determine the ideal ionic 
strength, different concentrations of NaCl (10, 20 and 30mM) were tried for to choose 
the probable conc. which  stabilize the coating of MUA-AuNPs with SST. 
Furthermore, the stability of the particles at different ionic strengths was determined by 
monitoring the change in the particles size, zeta potential and PDI. A concentration of 
10mM NaCl proved to be a suitable ionic strength for maintaining a small 
hydrodynamic diameter and low PDI of MUA-AuNPs during the coating and 
puriﬁcation processes. On the other hand, MUA-AuNPs with 20mM and 30mM NaCl, 
showed aggregation with undefined particle sizes. The PDI of MUA-AuNPs of 10mM 
NaCl was 0.2±0.04. In contrast, the PDI for 20 and 30mM NaCl was 0.34±0.8 and 
0.5±0.3; respectively as shown in (Figure 6) which indicated the beginning of particle 
aggregation and instability. This could be attributed to the increase in PDI in these 
higher molar concentrations. It was found that increasing the ionic strength led to a 
decrease in the Debye length between the particles concomitant with particles 
aggregation (48).  
Zeta potential analysis was performed for identification of the change in the surface 
charge of MUA-AuNPs at different ionic strengths (Figure 7). The MUA-AuNPs 
mixed with 100µL of 10mM NaCl had a high negative surface charge of -60.7±2.1 
owing to the presence of carboxylate anions from 11-MUA. Increasing the ionic 
strength to 20and 30mM decreased the negative surface potential to a value of -
20.6±0.5 and -19.7±6.8mV; respectively, leading to the aggregation of the 
nanoparticles as shown in (Figure 7). This was accompanied by a color change from 
red to blue as depicted in (Figure 2). This interaction is most likely due to increased 
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Van der Waals forces (46, 49-51). From the above results, it was clear that AuNPs are 
reasonably stable after 11-MUA coating and resist aggregation in the presence of up to 
10mM NaCl. 
Insert Figures 6 and 7 here. 
 
Coating of MUA-AuNPs with SST 
The coating process of SST on MUA-AUNPs could be performed according to the 
adsorption between oppositely charged groups. SST, which has a positive charge, was 
adsorbed on a negatively charged MUA-AuNPs. Different concentrations of SST were 
tried to choose the best and high-adsorbed amounts of SST. The amount of SST 
adsorbed to AuNPs seemed to increase from 20nM to 200nM. The particle sizes 
increased to 21.7±0.06, 22.4±0.3, 23.5±0.2, 25.05±0.07 and 28.3±0.4 for different SST 
concentrations of 20, 40, 60, 100 and 200nM; respectively with acceptable PDI as 
shown in (Table 1). After purification, the nanoparticles were stable without 
aggregation. However, particles coated with a concentration of 200nM SST showed 
aggregates after six hours, indicating that they are not acceptable preparations for a 
long-term stability. For that reason, the ideal SST concentration to be used for coating 
was chosen to be 100nM because the formed particles were stable in size and did not 
form aggregates.  
(Insert Table 1 here) 
Therefore, zeta potential was measured to confirm the successful coating of AuNPs 
with SST. Citrate-AuNPs had a zeta potential of -40.9±4.9mV. After deposition of 11-
MUA, it became more negative -60.8±2.65mV, indicating that citrate was replaced 
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with 11-MUA and the surface of gold coated carboxylic acid groups. Moreover, the 
zeta potential of all the investigated particles was initially negative then, after coating 
with different concentrations of 20-200nM SST, it became more and more positive.  
Furthermore, AuNPs-SST at 60, 100 and 200nM showed a reversal of the zeta potential 
values from negative to positive (16.9, 20.3 and 29.3mV; respectively, Table 1). Thus, 
zeta potential study proved the successful loading of SST on the surface of MUA-
AuNPs.  
The significance of 11-MUA for coating of SST-AuNPs 
Since the citrate-AuNPs have a negative surface charge and SST has a positive charge. 
SST might be deposited on the surface of AuNPs without of 11-MUA as an 
intermediate coating. To investigate this aspect, AuNPs were mixed with SST solution 
directly. The results of this experiment showed that 11-MUA is essential for coating of 
SST to AuNPs. Since, the absence of 11-MUA during the coating of citrate-AuNPs 
with SST led to an aggregation of AuNPs. Accordingly, the deposition of SST on 
MUA-AuNPs showed no aggregation even at higher concentration of SST about 
100nM (Figure 8a). While citrate-AuNPs formed aggregates after all purification steps 
even it was coated with 20nM of SST (Figure 8b).  
Insert Figure 8 a&b here 
Hence, it was worthy to use 11-MUA for coating of SST to AuNPs, since it make the 
AuNPs more stable and can adsorb easily SST. Furthermore, the aggregation observed 
in citrate-AuNPs could be possibly attributed to the failure of SST to replace the citrate 
anion on the surface of AuNPs which may formed as positive negative complex or 
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could be the disulfide bond of SST was reduced by citrate that make the particles 
aggregated. 
Dissociation of AuNPs-SST by sodium dodecyl sulphate (SDS) 
The effects of ionic surfactants like SDS on AuNPs-SST were studied using HPLC. At 
pH 7.0, anionic surfactants such as SDS induce peptide dissociation for AuNPs-SST. 
For this reason, SDS was used to confirm the adsorption of SST to AuNPs. Figure 9 
shows the chromatograms of SST and SST dissociated from AuNPs-SST. The 
dissociation of SST from AuNPs showed a single peak eluted at about 3.6 minutes. The 
chromatogram showed no degradation products. The SST dissociated from AuNPs was 
eluted earlier than the free SST, because it was less hydrophilic due to the presence of 
some traces of 11-MUA. Thus, confirmed the adsorption of SST to AuNPs, which then 
dissociated from the AuNPs with SDS. 
Insert Figure 9 here 
SST adsorbed to the surface of AuNPs was also analyzed using SDS-PAGE. Figure 10 
shows the SDS-PAGE containing a single band for AuNPs-SST (lane 5) that does not 
move. This confirmed the attachment of SST to the AuNPs which hinder the peptide 
from moving in the applied electric field(52-53). On the other hand, the 100nM 
concentration of SST and citrate-AuNPs showed no bands (lane 3 and lane 4; 
respectively). However, increasing the concentration of SST to 100nM resulted in 
appearance of band (lane 2) which is also confirmed the attachment of SST to AuNPs.  
Insert Figure 10 here 
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UV-VIS spectroscopy of AuNPs and AuNPs decorated with SST 
The optical properties of AuNPs are highly dependent on the nanoparticle 
diameter. Smaller nanoparticles absorb light and have peaks near 520nm, while larger 
spheres exhibit increased scattering and have peaks shifted towards longer wavelengths 
(known as red-shif). Furthermore, larger spheres scatter more light because they have 
larger optical cross sections, and their albedo (a ratio of scattering to total extinction) 
increases with size. AuNPs are often used as bio-imaging tags in dark field microscopy 
techniques, where the scattering from individual nanoparticles with diameters larger 
than 40-50nm can be observed(54). The UV-VIS spectra of citrate-AuNPs, MUA-
AuNPs and AuNPs-SST showed a small red shift in the surface Plasmon resonance 
peak. The shifts observed were of values of 5 and 4nm for MUA-AuNPs and AuNPs-
SST; respectively as shown in (Figure 11).  This could be possibly attributed to the 
deposition of 11-MUA and SST on AuNPs and increasing the nanoparticles size. 
Insert Figure 11 here 
Cellular uptake study   
To study the cellular uptake of AuNPs-SST, HCC-1806 cells were chosen as a model 
cell lines. HCC-1806 cells were incubated with citrate-AuNPs (as control 
nanoparticles) and AuNPs-SST for 1 hour in RPMI 1640 medium containing serum. 
HCC-1806 cells took up all types of AuNPs and the average amount of AuNPs per cell 
strongly depended on the type of the top layer. Since all kinds of AuNPs are of nearly 
similar sizes but possess different outer layers, this suggests that surface properties may 
strongly affect interactions with the cells. The number of AuNPs per cell was 
determined by ICP-OES. The initial concentration of AuNPs in the culture medium 
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was 100nM for citrate-AuNPs, MUA-AuNPs and AuNPs-SST. AuNPs-SST were 
internalized in significantly (p<0.05; ANOVA/Tukey) higher amounts (estimated 
number, 15393±656per cell) more than citrate-AuNPs and AuNPs-SST (estimated 
number 3779±758 and 8649±570per cell; respectively) in the presence of the 
antagonist (cyn 154806) as shown in (Figure 12). However, the higher amounts of 
antagonist up to 1mM displaced the nanoparticles from the receptor. Hence, it can be 
concluded that the difference in the cellular uptake of AuNPs-SST is due to differences 
in surface properties and not in the size of AuNPs. Nanoparticle interaction with cells 
is an issue of importance for targeting of these particles to different cells.  These results 
On the one hand there counteract the evidence of unwanted interactions such that 
particles enter cells with a non-specific way when they are exposed to colloids. SST as 
SSTRs agonist could easily fit on the SSTRs which increase the internalization of 
AuNPs, whilest blocking of these receptors by  antagonist like cyn-154806 led to 
internalization of AuNPs. 
Insert Figure 12 here 
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Conclusions 
Citrate-AuNPs were efficiently synthesized via the citrate-reduction method. They are 
uniform in size 19.3±0.5nm and had a negative charge of -43.4±0.5mV. Moreover, 
AuNPs were stable, resist the aggregation and successfully coated with SST after 
binding with 11-MUA instead of citrate ions. All analytical tools used in our study e.g., 
DLS, SDS-PAGE and UV-VIS absorption spectra confirmed the attachment of SST to 
AuNPs. In addition, significantly (p<0.05; ANOVA/Tukey) higher amounts AuNPs-
SST particles internalized per cell in HCC-1806 cell lines compared to citrate-AuNPs 
and AuNPs-SST in the presence of antagonists. Such internalization depends on the 
surface properties of the cells not on the size of particles as shown when the receptors 
were blocked by incorporation of antagonist. Finally, the proof of principle has been 
addressed and we will focusing our research in the future in the delivery of these novel 
AuNPs coated with SST to various tumor cells.   
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Figure 1: Schematic diagram for deposition of SST onto MUA-AuNPs. 10mM of NaCl used as isotonic 
solution. MUA-AuNPs was added drop-wise to 10µL of concentration of 100nM SST stirred for 30 minutes 
and purified by centrifugation at 15,700×g for 15 minutes.  
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Figure 2: Image of a) monodispersed AuNPs with red to purple color, b) polydispersed aggregated AuNPs 
with a blue color.  
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Figure 3: Particle size distribution, count rate as well as the polydispersity index (black diamond) of citrate-
AuNPs of 19nm using DLS.  
254x190mm (96 x 96 DPI)  
 
 
Page 27 of 42
URL: http:/mc.manuscriptcentral.com/lddi  Email:hugh.smyth@austin.utexas.edu
Drug Development and Industrial Pharmacy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
  
 
 
Figure 4: The hydrodynamic diameter as well as PDI of citrate-AuNPs, crude MUA-AuNPs and purified MUA-
AuNPs.  
254x190mm (96 x 96 DPI)  
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Figure 5: Zeta potential of citrate-AuNPs, crude MUA-AuNPs and purified MUA-AuNPs as a function of 
stability.  
254x190mm (96 x 96 DPI)  
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Figure 6: Influence of ionic strength on the polydispersity index of 11-MUA coated AuNPs. The PDI of MUA-
AuNPs with 10 mM NaCl is satisfactory low. In contrast, the PDI with 20 and 30 mM NaCl were much higher, 
which indicate the beginning of aggregation.  
254x190mm (96 x 96 DPI)  
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Figure 7: Zeta potential measurements of MUA-AuNPs at different ionic strength (10, 20 and 30)mM NaCl . 
The MUA-AuNPs mixed with 10mM NaCl had a high negative surface charge. Increasing the ionic strength to 
20 and 30mM, decreased the negative surface potential, leading to aggregation of the nanoparticles. This 
was accompanied by a color change from red to blue.  
254x190mm (96 x 96 DPI)  
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Figure 8: Particle size distribution of AuNPs measured using DLS. a). Coated with SST at concentration of 
100nM after deposition on MUA-AuNPs using 10mM NaCl as polyelectrolyte. b). Coated directly with SST at 
concentration of 20nM after deposition directly on citrate-AuNPs without using 10mM NaCl as 
polyelectrolyte.  
254x190mm (96 x 96 DPI)  
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Figure 9: HPLC chromatograms of SST dissociated from AuNPs-SST using SDS.  
254x190mm (72 x 72 DPI)  
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Figure 10: SDS-PAGE analysis for identification of the attachment of SST to AuNPs using 20% acrylamide, 
and protein ladder 19KDa. For identification of SST, a protein ladder was used (lane 1). High conc. of SST 
(10mM) (lane 2), 100nM SST (lane 3), citrate-AuNPs (lane 4) and 200nM AuNPs decorated with SST (lane 
5).  
97x101mm (72 x 72 DPI)  
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Figure 11: UV-VIS spectra of AuNPs, from top to bottom: citrate-AuNPs, purified AuNPs capped 11-MUA, and 
purified AuNPs decorated with SST.  
254x190mm (96 x 96 DPI)  
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Figure 12: The cellular uptake of AuNPs as determined by ICP-OES and cell counting after 1 hour of 
incubation. The concentration of AuNPs in the culture medium was 100nM for citrate-AuNPs, and AuNPs-
SST. * Significantly different (p<0.05; ANOVA/Tukey) verses citrate-AuNPs and AuNPS-SST (100nM + 
antagonist (1ml).  
190x142mm (96 x 96 DPI)  
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Table 1: Particle size by intensity (percentage), polydispersity index as well as zeta potential 
of AuNPs coated with different concentrations of SST. 
 
 
Parameters 
SST 
concentration 
(nM) 
Size (nm) PDI zeta  potential (mV) 
 
Citrate-AuNPs 
0 18.2±0.2 0.14 - 40.93±4.8 
MUA-AuNPs 0 20.2±0.1 0.12 - 60.63±2.6 
AuNPs-SST 20 21.7±0.1 0.2 - 46.8±2.6 
AuNPs-SST 40 22.5±0.3 0.1 - 22.7±1.9 
AuNPs-SST 60 23.5±0.2 0.2 16.9±2.9 
AuNPs-SST 100 25.1±0.1 0.1 20.3±1.3 
AuNPs-SST 200 28.3±0.4 0.2 29.3±1.3 
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Uptake: unmodified AuNPs per cell
Date 3/10/2013 Batch PCS: 20.83 nm
Concentration in solution/ in cells 
d [nm] 18
r  [nm] 9
Au
3+ 
[ppm] value cells [1 ppm = 1 mg/kg = 1 mg/l] 0.983333333
Au
3+ 
[g/l]  * 10
-3 
9.83E-04
Au
3+ 
[mol/l] Au
3+
 [g/l] / 197 g/mol [c=m/(M*V)] 4.99E-06
Number Au
3+ 
[1/l] Au
3+ 
[mol/l] * L 3.01E+18
Dilution ICP measurement 1 1
Au
3+ 
[mol/l] * Dilution 4.99E-06
Number Au
3+ 
[1/l] 3.01E+18
VAuNP [cm
3
] 4/3 * π * r
3 
* (10
-7
)
3
 (1nm = 10
-7
cm) 3.05E-18
mAuNP [g] 19.3 g/cm
3 
* VAuNP [cm
3
] 5.89E-17
Mol atoms per AuNP [mol] mAuNP / 197g/mol 2.99E-19
Atoms per AuNP Atoms per AuNP [mol] * L 1.80E+05
Number AuNP per l [1/l] Au
3+
 [1/l] * Atoms per AuNP 1.67E+13
AuNP [mol/l] Number AuNP per l / L 2.77E-11
Number AuNP per µl [1/µl] Number AuNP / l / 1000000 1.67E+07
Number AuNP 5 ml volumetric flask 8.34E+10
Concentration in cells
Number AuNP / 5 ml flask 8.34E+10
Number of cells total 21938000
Number AuNP / cell 3.80E+03
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Uptake: AuNPs-SST per cell
Date 3/10/2013 Batch PCS: 26.84 nm
Concentration in solution/ in cells 
d [nm] 25.1
r  [nm] 12.55
Au
3+ 
[ppm] value cells [1 ppm = 1 mg/kg = 1 mg/l] 10.7
Au
3+ 
[g/l]  * 10
-3 
1.07E-02
Au
3+ 
[mol/l] Au
3+
 [g/l] / 197 g/mol [c=m/(M*V)] 5.43E-05
Number Au
3+ 
[1/l] Au
3+ 
[mol/l] * L 3.27E+19
Dilution ICP measurement 1 1
Au
3+ 
[mol/l] * Dilution 5.43E-05
Number Au
3+ 
[1/l] 3.27E+19
VAuNP [cm
3
] 4/3 * π * r
3 
* (10
-7
)
3
 (1nm = 10
-7
cm) 8.28E-18
mAuNP [g] 19.3 g/cm
3 
* VAuNP [cm
3
] 1.60E-16
Mol atoms per AuNP [mol] mAuNP / 197g/mol 8.11E-19
Atoms per AuNP Atoms per AuNP [mol] * L 4.88E+05
Number AuNP per l [1/l] Au
3+
 [1/l] * Atoms per AuNP 6.70E+13
AuNP [mol/l] Number AuNP per l / L 1.11E-10
Number AuNP per µl [1/µl] Number AuNP / l / 1000000 6.70E+07
Number AuNP 5 ml volumetric flask 3.35E+11
Concentration in cells
Number AuNP / 5 ml flask 3.35E+11
Number of cells total 21938000
Number AuNP / cell 1.53E+04
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Conc of Au3+ [ppm]
13
11
9.01
9.45
10.78
11
sum 64.24
average 10.706667
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Uptake: AuNPs-SST& Antagonist per cell
Date 3/10/2013 Batch PCS: 26.84 nm
Concentration in solution/ in cells 
d [nm] 26.84
r  [nm] 13.42
Au
3+ 
[ppm] value cells [1 ppm = 1 mg/kg = 1 mg/l] 7.416666667
Au
3+ 
[g/l]  * 10
-3 
7.42E-03
Au
3+ 
[mol/l] Au
3+
 [g/l] / 197 g/mol [c=m/(M*V)] 3.76E-05
Number Au
3+ 
[1/l] Au
3+ 
[mol/l] * L 2.27E+19
Dilution ICP measurement 1 1
Au
3+ 
[mol/l] * Dilution 3.76E-05
Number Au
3+ 
[1/l] 2.27E+19
VAuNP [cm
3
] 4/3 * π * r
3 
* (10
-7
)
3
 (1nm = 10
-7
cm) 1.01E-17
mAuNP [g] 19.3 g/cm
3 
* VAuNP [cm
3
] 1.95E-16
Mol atoms per AuNP [mol] mAuNP / 197g/mol 9.92E-19
Atoms per AuNP Atoms per AuNP [mol] * L 5.97E+05
Number AuNP per l [1/l] Au
3+
 [1/l] * Atoms per AuNP 3.80E+13
AuNP [mol/l] Number AuNP per l / L 6.30E-11
Number AuNP per µl [1/µl] Number AuNP / l / 1000000 3.80E+07
Number AuNP 5 ml volumetric flask 1.90E+11
Concentration in cells
Number AuNP / 5 ml flask 1.90E+11
Number of cells total 21938000
Number AuNP / cell 8.65E+03
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Conc of Au3+ [ppm]
6.9
7.3
8.2
7.2
7.3
7.6
sum 44.5
average 7.4166667
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